Congenital Adrenal Hyperplasia (CAH) Market, Global Outlook and Forecast 2023-2029

Report ID: MMG194223 | Category: Medical Devices & Consumables | Pages: 64 | Format: PDF | Published Date: September 04,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

Congenital adrenal hyperplasia (CAH) is a group of rare inherited autosomal recessive disorders characterized by a deficiency of one of the enzymes needed to make specific hormones. Congenital adrenal hyperplasia (CAH) refers to a group of genetic disorders that affect the adrenal glands, a pair of walnut-sized organs above the kidneys. The adrenal glands produce important hormones, including: Cortisol, which regulates the body's response to illness or stress.
This report aims to provide a comprehensive presentation of the global market for Congenital Adrenal Hyperplasia (CAH), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Congenital Adrenal Hyperplasia (CAH). This report contains market size and forecasts of Congenital Adrenal Hyperplasia (CAH) in global, including the following market information:
Global Congenital Adrenal Hyperplasia (CAH) Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Congenital Adrenal Hyperplasia (CAH) market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Classic Congenital Adrenal Hyperplasia Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Congenital Adrenal Hyperplasia (CAH) include Medline Industries, Cook Medical, Cooper Surgical, Smiths Medical, Becton, Dickinson and Company, Rocket Medical Plc, CENTOGENE N.V and Eurofins Scientific, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Congenital Adrenal Hyperplasia (CAH) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Congenital Adrenal Hyperplasia (CAH) Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Congenital Adrenal Hyperplasia (CAH) Market Segment Percentages, by Type, 2022 (%)
    Classic Congenital Adrenal Hyperplasia
    Non-classic Congenital Adrenal Hyperplasia
    Others
Global Congenital Adrenal Hyperplasia (CAH) Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Congenital Adrenal Hyperplasia (CAH) Market Segment Percentages, by Application, 2022 (%)
    Hospitals
    Diagnostic Centers
    Outpatient Surgery Centers
    Clinics
    Others
Global Congenital Adrenal Hyperplasia (CAH) Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Congenital Adrenal Hyperplasia (CAH) Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Congenital Adrenal Hyperplasia (CAH) revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Congenital Adrenal Hyperplasia (CAH) revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Medline Industries
    Cook Medical
    Cooper Surgical
    Smiths Medical
    Becton
    Dickinson and Company
    Rocket Medical Plc
    CENTOGENE N.V
    Eurofins Scientific
    PerkinElmer Inc
    F. Hoffmann-La Roche AG
Outline of Major Chapters:
Chapter 1: Introduces the definition of Congenital Adrenal Hyperplasia (CAH), market overview.
Chapter 2: Global Congenital Adrenal Hyperplasia (CAH) market size in revenue.
Chapter 3: Detailed analysis of Congenital Adrenal Hyperplasia (CAH) company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Congenital Adrenal Hyperplasia (CAH) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Congenital Adrenal Hyperplasia (CAH) Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Congenital Adrenal Hyperplasia (CAH) Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Congenital Adrenal Hyperplasia (CAH) Overall Market Size
    2.1 Global Congenital Adrenal Hyperplasia (CAH) Market Size: 2022 VS 2029
    2.2 Global Congenital Adrenal Hyperplasia (CAH) Market Size, Prospects & Forecasts: 2018-2029
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Congenital Adrenal Hyperplasia (CAH) Players in Global Market
    3.2 Top Global Congenital Adrenal Hyperplasia (CAH) Companies Ranked by Revenue
    3.3 Global Congenital Adrenal Hyperplasia (CAH) Revenue by Companies
    3.4 Top 3 and Top 5 Congenital Adrenal Hyperplasia (CAH) Companies in Global Market, by Revenue in 2022
    3.5 Global Companies Congenital Adrenal Hyperplasia (CAH) Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Congenital Adrenal Hyperplasia (CAH) Players in Global Market
        3.6.1 List of Global Tier 1 Congenital Adrenal Hyperplasia (CAH) Companies
        3.6.2 List of Global Tier 2 and Tier 3 Congenital Adrenal Hyperplasia (CAH) Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Congenital Adrenal Hyperplasia (CAH) Market Size Markets, 2022 & 2029
        4.1.2 Classic Congenital Adrenal Hyperplasia
        4.1.3 Non-classic Congenital Adrenal Hyperplasia
        4.1.4 Others
    4.2 By Type - Global Congenital Adrenal Hyperplasia (CAH) Revenue & Forecasts
        4.2.1 By Type - Global Congenital Adrenal Hyperplasia (CAH) Revenue, 2018-2023
        4.2.2 By Type - Global Congenital Adrenal Hyperplasia (CAH) Revenue, 2024-2029
        4.2.3 By Type - Global Congenital Adrenal Hyperplasia (CAH) Revenue Market Share, 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Congenital Adrenal Hyperplasia (CAH) Market Size, 2022 & 2029
        5.1.2 Hospitals
        5.1.3 Diagnostic Centers
        5.1.4 Outpatient Surgery Centers
        5.1.5 Clinics
        5.1.6 Others
    5.2 By Application - Global Congenital Adrenal Hyperplasia (CAH) Revenue & Forecasts
        5.2.1 By Application - Global Congenital Adrenal Hyperplasia (CAH) Revenue, 2018-2023
        5.2.2 By Application - Global Congenital Adrenal Hyperplasia (CAH) Revenue, 2024-2029
        5.2.3 By Application - Global Congenital Adrenal Hyperplasia (CAH) Revenue Market Share, 2018-2029
6 Sights by Region
    6.1 By Region - Global Congenital Adrenal Hyperplasia (CAH) Market Size, 2022 & 2029
    6.2 By Region - Global Congenital Adrenal Hyperplasia (CAH) Revenue & Forecasts
        6.2.1 By Region - Global Congenital Adrenal Hyperplasia (CAH) Revenue, 2018-2023
        6.2.2 By Region - Global Congenital Adrenal Hyperplasia (CAH) Revenue, 2024-2029
        6.2.3 By Region - Global Congenital Adrenal Hyperplasia (CAH) Revenue Market Share, 2018-2029
    6.3 North America
        6.3.1 By Country - North America Congenital Adrenal Hyperplasia (CAH) Revenue, 2018-2029
        6.3.2 US Congenital Adrenal Hyperplasia (CAH) Market Size, 2018-2029
        6.3.3 Canada Congenital Adrenal Hyperplasia (CAH) Market Size, 2018-2029
        6.3.4 Mexico Congenital Adrenal Hyperplasia (CAH) Market Size, 2018-2029
    6.4 Europe
        6.4.1 By Country - Europe Congenital Adrenal Hyperplasia (CAH) Revenue, 2018-2029
        6.4.2 Germany Congenital Adrenal Hyperplasia (CAH) Market Size, 2018-2029
        6.4.3 France Congenital Adrenal Hyperplasia (CAH) Market Size, 2018-2029
        6.4.4 U.K. Congenital Adrenal Hyperplasia (CAH) Market Size, 2018-2029
        6.4.5 Italy Congenital Adrenal Hyperplasia (CAH) Market Size, 2018-2029
        6.4.6 Russia Congenital Adrenal Hyperplasia (CAH) Market Size, 2018-2029
        6.4.7 Nordic Countries Congenital Adrenal Hyperplasia (CAH) Market Size, 2018-2029
        6.4.8 Benelux Congenital Adrenal Hyperplasia (CAH) Market Size, 2018-2029
    6.5 Asia
        6.5.1 By Region - Asia Congenital Adrenal Hyperplasia (CAH) Revenue, 2018-2029
        6.5.2 China Congenital Adrenal Hyperplasia (CAH) Market Size, 2018-2029
        6.5.3 Japan Congenital Adrenal Hyperplasia (CAH) Market Size, 2018-2029
        6.5.4 South Korea Congenital Adrenal Hyperplasia (CAH) Market Size, 2018-2029
        6.5.5 Southeast Asia Congenital Adrenal Hyperplasia (CAH) Market Size, 2018-2029
        6.5.6 India Congenital Adrenal Hyperplasia (CAH) Market Size, 2018-2029
    6.6 South America
        6.6.1 By Country - South America Congenital Adrenal Hyperplasia (CAH) Revenue, 2018-2029
        6.6.2 Brazil Congenital Adrenal Hyperplasia (CAH) Market Size, 2018-2029
        6.6.3 Argentina Congenital Adrenal Hyperplasia (CAH) Market Size, 2018-2029
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Congenital Adrenal Hyperplasia (CAH) Revenue, 2018-2029
        6.7.2 Turkey Congenital Adrenal Hyperplasia (CAH) Market Size, 2018-2029
        6.7.3 Israel Congenital Adrenal Hyperplasia (CAH) Market Size, 2018-2029
        6.7.4 Saudi Arabia Congenital Adrenal Hyperplasia (CAH) Market Size, 2018-2029
        6.7.5 UAE Congenital Adrenal Hyperplasia (CAH) Market Size, 2018-2029
7 Congenital Adrenal Hyperplasia (CAH) Companies Profiles
    7.1 Medline Industries
        7.1.1 Medline Industries Company Summary
        7.1.2 Medline Industries Business Overview
        7.1.3 Medline Industries Congenital Adrenal Hyperplasia (CAH) Major Product Offerings
        7.1.4 Medline Industries Congenital Adrenal Hyperplasia (CAH) Revenue in Global Market (2018-2023)
        7.1.5 Medline Industries Key News & Latest Developments
    7.2 Cook Medical
        7.2.1 Cook Medical Company Summary
        7.2.2 Cook Medical Business Overview
        7.2.3 Cook Medical Congenital Adrenal Hyperplasia (CAH) Major Product Offerings
        7.2.4 Cook Medical Congenital Adrenal Hyperplasia (CAH) Revenue in Global Market (2018-2023)
        7.2.5 Cook Medical Key News & Latest Developments
    7.3 Cooper Surgical
        7.3.1 Cooper Surgical Company Summary
        7.3.2 Cooper Surgical Business Overview
        7.3.3 Cooper Surgical Congenital Adrenal Hyperplasia (CAH) Major Product Offerings
        7.3.4 Cooper Surgical Congenital Adrenal Hyperplasia (CAH) Revenue in Global Market (2018-2023)
        7.3.5 Cooper Surgical Key News & Latest Developments
    7.4 Smiths Medical
        7.4.1 Smiths Medical Company Summary
        7.4.2 Smiths Medical Business Overview
        7.4.3 Smiths Medical Congenital Adrenal Hyperplasia (CAH) Major Product Offerings
        7.4.4 Smiths Medical Congenital Adrenal Hyperplasia (CAH) Revenue in Global Market (2018-2023)
        7.4.5 Smiths Medical Key News & Latest Developments
    7.5 Becton
        7.5.1 Becton Company Summary
        7.5.2 Becton Business Overview
        7.5.3 Becton Congenital Adrenal Hyperplasia (CAH) Major Product Offerings
        7.5.4 Becton Congenital Adrenal Hyperplasia (CAH) Revenue in Global Market (2018-2023)
        7.5.5 Becton Key News & Latest Developments
    7.6 Dickinson and Company
        7.6.1 Dickinson and Company Company Summary
        7.6.2 Dickinson and Company Business Overview
        7.6.3 Dickinson and Company Congenital Adrenal Hyperplasia (CAH) Major Product Offerings
        7.6.4 Dickinson and Company Congenital Adrenal Hyperplasia (CAH) Revenue in Global Market (2018-2023)
        7.6.5 Dickinson and Company Key News & Latest Developments
    7.7 Rocket Medical Plc
        7.7.1 Rocket Medical Plc Company Summary
        7.7.2 Rocket Medical Plc Business Overview
        7.7.3 Rocket Medical Plc Congenital Adrenal Hyperplasia (CAH) Major Product Offerings
        7.7.4 Rocket Medical Plc Congenital Adrenal Hyperplasia (CAH) Revenue in Global Market (2018-2023)
        7.7.5 Rocket Medical Plc Key News & Latest Developments
    7.8 CENTOGENE N.V
        7.8.1 CENTOGENE N.V Company Summary
        7.8.2 CENTOGENE N.V Business Overview
        7.8.3 CENTOGENE N.V Congenital Adrenal Hyperplasia (CAH) Major Product Offerings
        7.8.4 CENTOGENE N.V Congenital Adrenal Hyperplasia (CAH) Revenue in Global Market (2018-2023)
        7.8.5 CENTOGENE N.V Key News & Latest Developments
    7.9 Eurofins Scientific
        7.9.1 Eurofins Scientific Company Summary
        7.9.2 Eurofins Scientific Business Overview
        7.9.3 Eurofins Scientific Congenital Adrenal Hyperplasia (CAH) Major Product Offerings
        7.9.4 Eurofins Scientific Congenital Adrenal Hyperplasia (CAH) Revenue in Global Market (2018-2023)
        7.9.5 Eurofins Scientific Key News & Latest Developments
    7.10 PerkinElmer Inc
        7.10.1 PerkinElmer Inc Company Summary
        7.10.2 PerkinElmer Inc Business Overview
        7.10.3 PerkinElmer Inc Congenital Adrenal Hyperplasia (CAH) Major Product Offerings
        7.10.4 PerkinElmer Inc Congenital Adrenal Hyperplasia (CAH) Revenue in Global Market (2018-2023)
        7.10.5 PerkinElmer Inc Key News & Latest Developments
    7.11 F. Hoffmann-La Roche AG
        7.11.1 F. Hoffmann-La Roche AG Company Summary
        7.11.2 F. Hoffmann-La Roche AG Business Overview
        7.11.3 F. Hoffmann-La Roche AG Congenital Adrenal Hyperplasia (CAH) Major Product Offerings
        7.11.4 F. Hoffmann-La Roche AG Congenital Adrenal Hyperplasia (CAH) Revenue in Global Market (2018-2023)
        7.11.5 F. Hoffmann-La Roche AG Key News & Latest Developments
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Congenital Adrenal Hyperplasia (CAH) Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?